Christopher W. Armstrong

853 total citations
23 papers, 489 citations indexed

About

Christopher W. Armstrong is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Computer Networks and Communications. According to data from OpenAlex, Christopher W. Armstrong has authored 23 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Computer Networks and Communications. Recurrent topics in Christopher W. Armstrong's work include Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers), Genetic Neurodegenerative Diseases (8 papers) and Distributed and Parallel Computing Systems (4 papers). Christopher W. Armstrong is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (15 papers), Genetic Neurodegenerative Diseases (8 papers) and Distributed and Parallel Computing Systems (4 papers). Christopher W. Armstrong collaborates with scholars based in Australia, United Kingdom and Canada. Christopher W. Armstrong's co-authors include Paul R. Gooley, Neil McGregor, Henry L. Butt, Donald P. Lewis, Natalie Thomas, Graham Riley, Rupert Ford, Caroline Gurvich, John R. Sheedy and I. Buttfield and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Frontiers in Immunology.

In The Last Decade

Christopher W. Armstrong

20 papers receiving 476 citations

Peers

Countries citing papers authored by Christopher W. Armstrong

Since Specialization

Citations

This map shows the geographic impact of Christopher W. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Armstrong more than expected).

Fields of papers citing papers by Christopher W. Armstrong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher W. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Armstrong. The network helps show where Christopher W. Armstrong may publish in the future.

Co-authorship network of co-authors of Christopher W. Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher W. Armstrong. A scholar is included among the top collaborators of Christopher W. Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher W. Armstrong. Christopher W. Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mapping cerebral blood flow in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and orthostatic intolerance: insights from a systematic review 2025 ·Journal of Translational Medicine ·(unknown), (unknown), (unknown), Elena K. Schneider‐Futschik, Paul R. Gooley, Kegan Moneghetti, Christopher W. Armstrong	1
2	Machine learning and multi-omics in precision medicine for ME/CFS 2025 ·Journal of Translational Medicine ·(unknown), Brett A. Lidbury, Natalie Thomas, Paul R. Gooley, Christopher W. Armstrong	7
3	A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVID 2025 ·ACS Pharmacology & Translational Science ·Daniel Fineberg, Alain Moreau, Elena K. Schneider‐Futschik, Christopher W. Armstrong	0
4	Serial Paediatrics Omics Tracking in Myalgic Encephalomyelitis (SPOT-ME): protocol paper for a multidisciplinary, observational study of clinical and biological markers of paediatric myalgic encephalomyelitis/chronic fatigue syndrome in Australian adolescents aged 12–19 years 2024 ·BMJ Open ·Natalie Thomas, (unknown), (unknown), (unknown), Adam Scheinberg, Paul R. Gooley, Elisha K. Josev, Sarah Knight, Christopher W. Armstrong	0
5	Discriminating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and comorbid conditions using metabolomics in UK Biobank 2024 ·SHILAP Revista de lepidopterología ·(unknown), Alex G. C. de Sá, Natalie Thomas, Robert D. Phair, Paul R. Gooley, David B. Ascher, Christopher W. Armstrong	4
6	In vitro B cell experiments explore the role of CD24, CD38, and energy metabolism in ME/CFS 2024 ·Frontiers in Immunology ·Christopher W. Armstrong, (unknown), Maria Leandro, Venkat Reddy, Paul R. Gooley, Saul Berkovitz, Geraldine Cambridge	4
7	Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies 2024 ·Trends in Molecular Medicine ·Sarah J. Annesley, Daniel Missailidis, Benjamin Heng, Elisha K. Josev, Christopher W. Armstrong	16
8	Systematic Review of NMR-Based Metabolomics Practices in Human Disease Research 2022 ·Metabolites ·(unknown), Natalie Thomas, Paul R. Gooley, Christopher W. Armstrong	18
9	The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome 2022 ·Frontiers in Neuroendocrinology ·Natalie Thomas, Caroline Gurvich, (unknown), Paul R. Gooley, Christopher W. Armstrong	35
10	A network meta-analysis of stress mediators in suicide behaviour 2021 ·Frontiers in Neuroendocrinology ·Natalie Thomas, Christopher W. Armstrong, Abdul‐Rahman Hudaib, Jayashri Kulkarni, Caroline Gurvich	18
11	CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 2018 ·Frontiers in Immunology ·(unknown), Christopher W. Armstrong, Venkat Reddy, Amolak S. Bansal, Saul Berkovitz, Maria Leandro, Geraldine Cambridge	35
12	Abstract A087: Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in preclinical models of prostate cancer 2018 ·Cancer Research ·Pamela Maxwell, (unknown), (unknown), Christopher W. Armstrong, (unknown), Chee Wee Ong, Jenny Worthington, Elena I. Deryugina, James P. Quigley, Amina Zoubeidi, David Waugh, Melissa J. LaBonte	1
13	The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome 2016 ·Metabolomics ·Christopher W. Armstrong, Neil McGregor, Donald P. Lewis, Henry L. Butt, Paul R. Gooley	58
14	Widespread pain and altered renal function in ME/CFS patients 2016 ·Fatigue Biomedicine Health & Behavior ·Neil McGregor, Christopher W. Armstrong, Donald P. Lewis, Henry L. Butt, Paul R. Gooley	3
15	Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients 2015 ·Metabolomics ·Christopher W. Armstrong, Neil McGregor, Donald P. Lewis, Henry L. Butt, Paul R. Gooley	107
16	Metabolism in Chronic Fatigue Syndrome 2014 ·Advances in clinical chemistry ·Christopher W. Armstrong, Neil McGregor, Henry L. Butt, Paul R. Gooley	52
17	NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome 2012 ·Clinica Chimica Acta ·Christopher W. Armstrong, Neil McGregor, John R. Sheedy, I. Buttfield, Henry L. Butt, Paul R. Gooley	55
18	Coupling integrated Earth System Model components with BFG2 2008 ·Concurrency and Computation Practice and Experience ·Christopher W. Armstrong, Rupert Ford, Graham Riley	21
19	GCF: a general coupling framework 2005 ·Concurrency and Computation Practice and Experience ·Rupert Ford, Graham Riley, Michael Bane, Christopher W. Armstrong, (unknown)	14
20	196. Risk Assessment, Scenario Planning, and Competitive Advantage 2002 ·AIHce 2002 ·Christopher W. Armstrong	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact